Analysis of Glucose Levels in Patients Hospitalized With COVID-19 During the First Phase of This Pandemic in West Texas

Background: Patients with hyperglycemia during hospitalization, especially during ICU hospitalizations, often have worse outcomes, even if they do not have a premorbid diagnosis of diabetes. High glucose levels can provide insight into the underlying pathogenesis of a disease and can contribute to tissue injury. Some patients with COVID-19 have hyperglycemia during hospitalizations. Methods: The Infectious Disease and Control office at University Medical Center in Lubbock, Texas, provided a list of patients with a COVID-19 infection hospitalized between March 1 and May 15, 2020. The medical records were reviewed to collect information on age, gender, history of diabetes, and glucose levels on admission and through the first 7 days of hospitalization. Results: This study included 63 patients with a mean age of 62.1 ± 14.1 years. Thirty-five patients (55.6%) were males. The in-hospital mortality rate was 30.2%. The mean admission glucose level was 129.4 ± 57.1 mg/dL in patients who survived (N = 47) and 189.6 ± 112.2 mg/dL in patients who died during hospitalization (N = 16, P = .007). An admission glucose greater than 180 mg/dL predicted mortality in a model adjusted for a diabetes, age, and male gender. The mean differences between the maximum and minimum glucose levels calculated over the first 7 days of hospitalization were 112.93 ± 115.4 (N = 47) in patients who survived and were 240.5 ± 97.7 (N = 15) in patients who died during hospitalization (P = .0003). A difference between the maximum and minimum glucose level greater than 105 mg/dL was associated with increased mortality. Conclusions: Patients who died during hospitalization for COVID-19 had higher admission glucose levels than patients who survived. Larger differences between maximum and minimum glucose levels during the first 7 days of hospitalization were associated with increased mortality. These results suggest that high glucose levels identify patients at increased risk for mortality and warrant more study.

[1]  Feng Wu,et al.  Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study , 2020, Diabetologia.

[2]  K. H. Chan,et al.  Clinical characteristics and outcome in patients with combined diabetic ketoacidosis and hyperosmolar hyperglycemic state associated with COVID-19: A retrospective, hospital-based observational case series , 2020, Diabetes Research and Clinical Practice.

[3]  D. Klonoff,et al.  Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States , 2020, Journal of diabetes science and technology.

[4]  G. Iacobellis,et al.  Admission hyperglycemia and radiological findings of SARS-CoV2 in patients with and without diabetes , 2020, Diabetes Research and Clinical Practice.

[5]  A. Ceriello.  Hyperglycemia and the worse prognosis of COVID-19. Why a fast blood glucose control should be mandatory , 2020, Diabetes Research and Clinical Practice.

[6]  Furong Liu,et al.  ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection , 2020, Clinical Gastroenterology and Hepatology.

[7]  Qiu Zhao,et al.  Pancreatic Injury Patterns in Patients With Coronavirus Disease 19 Pneumonia , 2020, Gastroenterology.

[8]  K. Nugent,et al.  Advanced glycation end products and glycosaminoglycans in patients with diabetic ketoacidosis , 2019, Journal of Investigative Medicine.

[9]  Shengping Yang,et al.  Glucose and Lactate Levels at Admission as Predictors of In-hospital Mortality , 2019, Cureus.

[10]  Shengping Yang,et al.  The association between admission glucose levels and outcomes in adults admitted to a tertiary care hospital , 2019, Journal of community hospital internal medicine perspectives.

[11]  W. Manzanares,et al.  Dysglycemia in the critically ill patient: current evidence and future perspectives , 2017, Revista Brasileira de terapia intensiva.

[12]  G. Umpierrez,et al.  Management of Inpatient Hyperglycemia and Diabetes in Older Adults , 2017, Diabetes Care.

[13]  T. van der Poll,et al.  Admission Hyperglycemia in Critically Ill Sepsis Patients: Association With Outcome and Host Response* , 2016, Critical care medicine.

[14]  K. Nugent,et al.  Hyperglycemia and outcomes in patients with sepsis. , 2016, Journal of thoracic disease.

[15]  K. Nugent,et al.  The Effect of Short‐Term Hyperglycemia on the Innate Immune System , 2016, The American journal of the medical sciences.

[16]  Juan Li,et al.  The association of oxidative stress and pro-inflammatory cytokines in diabetic patients with hyperglycemic crisis. , 2014, Journal of diabetes and its complications.

[17]  Jin-Kui Yang,et al.  Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes , 2009, Acta Diabetologica.

[18]  R. Testa,et al.  Oscillating Glucose Is More Deleterious to Endothelial Function and Oxidative Stress Than Mean Glucose in Normal and Type 2 Diabetic Patients , 2008, Diabetes.